Summary: Measurements of individual alpha wave frequency can reliably predict how a person will experience prolonged pain.
Source: University of Birmingham
New research shows that the brain’s rhythmic alpha activity provides a reliable indicator of a person’s sensitivity or resilience to pain.
The living brain generates ongoing rhythmic electrical activity that can be measured and compared to musical tones. Researchers from the University of Birmingham (UK) and the University of Maryland School of Dentistry (US) focused on one dominant rhythm, known as alpha waves, and found that the peak frequency of an individual’s alpha rhythm closely relates to how they experience prolonged pain.
Alpha oscillations typically appear in the range around 8–14 Hz, with most people showing a characteristic peak frequency that varies from person to person. The study demonstrates that by measuring this individual peak alpha frequency (PAF) with resting electroencephalography (EEG), clinicians can gain a consistent, objective marker of pain sensitivity.
Led by graduate student Andrew Furman and published in the journal Cerebral Cortex, the study suggests that sensorimotor peak alpha frequency may serve as a biomarker to predict which patients are likely to experience intense post-surgical pain and which are likely to be more resilient.
Dr David Seminowicz of the University of Maryland School of Dentistry, a co-author, said understanding a patient’s baseline pain sensitivity could help guide clinical decisions. For example, knowledge of heightened sensitivity might influence whether to proceed with an elective procedure, how to plan post-operative care, or whether to introduce preoperative interventions such as targeted pain management or mindfulness training to reduce later suffering.
Dr Ali Mazaheri of the University of Birmingham’s School of Psychology and Centre for Human Brain Health, also a co-author, notes that severe acute pain after surgery is often a predictor of long-term chronic pain. Identifying patients at higher risk ahead of time could allow clinicians and patients to weigh alternative treatments, intensify rehabilitation efforts, or tailor pain-control strategies to reduce the chance of chronic pain developing.
Alpha rhythms are one of several ongoing electrical patterns in the resting brain. They tend to be more prominent when a person is awake but not actively engaged, and fluctuations in alpha power and frequency indicate changes in how sensory systems are prepared to process input. Faster peak alpha frequencies have been associated with greater resilience to prolonged pain, while slower alpha peaks have been linked to increased pain sensitivity.
In the study, 61 healthy volunteers (both men and women) aged 21–42 underwent resting EEG to record their baseline alpha activity. Each participant experienced two models of prolonged pain: a capsaicin-induced sensitisation, produced by applying a cream containing capsaicin (the active component in chili peppers), and repeated applications of heat (phasic heat pain). Participants returned for a second session about eight weeks later to test the stability of the findings over time.
The researchers found that an individual’s pain-free peak alpha frequency reliably predicted their sensitivity to both pain models. Those with slower peak alpha frequencies were, on average, more sensitive to prolonged pain, while those with faster alpha peaks showed more resilience. Importantly, the relationship held both within the single testing session and across the eight-week follow-up, indicating that PAF is a stable, trait-like indicator of prolonged pain sensitivity.
The Birmingham team is already collaborating with clinicians at Heartlands and Queen Elizabeth Hospitals to translate these findings into clinical practice. Dr Mazaheri is leading a clinical study using alpha frequency measurements to assess pain risk in lung cancer patients undergoing lung biopsy and surgery, procedures known to carry a high risk of severe post-operative pain. By identifying patients at greatest risk, clinicians hope to personalise care pathways—considering alternative treatments such as radiotherapy where appropriate, intensifying rehabilitation, or planning enhanced analgesic support to reduce the likelihood of persistent pain.
The research team is actively seeking funding to expand clinical trials and validate the use of peak alpha frequency as a practical biomarker for predicting pain sensitivity before surgery or other medical procedures.
About this pain research article
Source:
University of Birmingham
Contacts:
R Lockwood – University of Birmingham
Image Source:
The image is in the public domain.
Original Research:
“Sensorimotor Peak Alpha Frequency Is a Reliable Biomarker of Prolonged Pain Sensitivity” by Furman et al., Cerebral Cortex (closed access).
Abstract
Sensorimotor Peak Alpha Frequency Is a Reliable Biomarker of Prolonged Pain Sensitivity
Previous studies have observed that the speed of alpha-band oscillations recorded during resting EEG is often slowed in chronic pain patients. One possibility is that this slowing reflects changes that occur after pain becomes chronic. An alternative explanation is that healthy individuals with inherently slower alpha oscillations are more sensitive to prolonged pain and therefore at greater risk of developing chronic pain. To investigate this, the authors measured resting, pain-free alpha oscillation speed in healthy volunteers and tested their sensitivity to two prolonged pain models—Phasic Heat Pain and Capsaicin Heat Pain—at two visits separated by about eight weeks (n = 61 at Visit 1, n = 46 at Visit 2). The study found a negative correlation between resting alpha speed and pain sensitivity for both models, a relationship that was consistent across short (minutes) and longer (weeks) timescales. The speed of pain-free alpha oscillations also successfully identified the most pain-sensitive individuals, a result validated using data from an independent dataset. These findings support the use of peak alpha frequency as a reliable biomarker for prolonged pain sensitivity with potential clinical utility in prospectively identifying individuals at risk.